Motus GI Holdings Inc
F:7M40

Watchlist Manager
Motus GI Holdings Inc Logo
Motus GI Holdings Inc
F:7M40
Watchlist
Price: 8.25 EUR Market Closed
Market Cap: 223.9k EUR

Motus GI Holdings Inc
Common Shares Outstanding

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
|
See Also

Motus GI Holdings Inc
Common Shares Outstanding Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Common Shares Outstanding CAGR 3Y CAGR 5Y CAGR 10Y
Motus GI Holdings Inc
F:7M40
Common Shares Outstanding
$5.2m
CAGR 3-Years
219%
CAGR 5-Years
137%
CAGR 10-Years
N/A
Becton Dickinson and Co
NYSE:BDX
Common Shares Outstanding
$285.4m
CAGR 3-Years
0%
CAGR 5-Years
0%
CAGR 10-Years
3%
Boston Scientific Corp
NYSE:BSX
Common Shares Outstanding
$1.5B
CAGR 3-Years
1%
CAGR 5-Years
1%
CAGR 10-Years
1%
Stryker Corp
NYSE:SYK
Common Shares Outstanding
$382.3m
CAGR 3-Years
0%
CAGR 5-Years
0%
CAGR 10-Years
0%
Abbott Laboratories
NYSE:ABT
Common Shares Outstanding
$1.7B
CAGR 3-Years
0%
CAGR 5-Years
0%
CAGR 10-Years
2%
Intuitive Surgical Inc
NASDAQ:ISRG
Common Shares Outstanding
$358.5m
CAGR 3-Years
0%
CAGR 5-Years
0%
CAGR 10-Years
1%
No Stocks Found

Motus GI Holdings Inc
Glance View

Market Cap
223.9k EUR
Industry
Health Care

Motus GI Holdings, Inc. is a medical technology company, which is dedicated to improving endoscopy outcomes and experiences. The company is headquartered in Fort Lauderdale, Florida and currently employs 30 full-time employees. The company went IPO on 2018-02-14. The firm is engaged in developing a medical device Pure-Vu System. Pure-Vu system consists of a workstation controller and a single-use, disposable sleeve that fits over standard and slim colonoscopes. The Pure-Vu System facilitates the cleaning of the colon during the colonoscopy procedure. Pure-Vu System integrates with standard and slim colonoscopes to enable safe and rapid cleansing during the procedure while preserving established procedural workflow and techniques by irrigating the colon and evacuating the irrigation fluid (water), feces and other bodily fluids and matter. The firm is focused on GI bleeds clinical research . The firm's subsidiaries include Motus GI Medical Technologies, Ltd. and Motus GI, LLC.

7M40 Intrinsic Value
Not Available

See Also

What is Motus GI Holdings Inc's Common Shares Outstanding?
Common Shares Outstanding
5.2m USD

Based on the financial report for Mar 31, 2024, Motus GI Holdings Inc's Common Shares Outstanding amounts to 5.2m USD.

What is Motus GI Holdings Inc's Common Shares Outstanding growth rate?
Common Shares Outstanding CAGR 5Y
137%

Over the last year, the Common Shares Outstanding growth was 1 528%. The average annual Common Shares Outstanding growth rates for Motus GI Holdings Inc have been 219% over the past three years , 137% over the past five years .

Back to Top